Clinical Applications of Metabolomics in Oncology: A Review von SPRATLIN, Jennifer L, SERKOVA, NatalieJ, GAIL ECKHARDT, S

Volltext

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2 von SPRATLIN, Jennifer L, COHEN, Roger B, MEROPOL, Neal J, LEWIS, Nancy L, CHIOREAN, E. Gabriela, FOX, Floyd, YOUSSOUFIAN, Hagop, ROWINSKY, Eric K, GAIL ECKHARDT, S, EADENS, Matthew, GORE, Lia, CAMIDGE, D. Ross, DIAB, Sami, LEONG, Stephen, O'BRYANT, Cindy, CHOW, Laura Q. M, SERKOVA, Natalie J

Volltext

A Population-Based Retrospective Study of Biliary Tract Cancers in Alberta, Canada von Beaulieu, Carissa, Lui, Arthur, Yusuf, Dimas, Abdelaziz, Zainab, Randolph, Brock, Batuyong, Eugene, Ghosh, Sunita, Bathe, Oliver F., Tam, Vincent, Spratlin, Jennifer L.

Volltext

Prolonged Response to Regorafenib in a Patient with Iodine Refractory Thyroid Cancer von Wong, Selina K., Chu, Quincy S.C., Spratlin, Jennifer L., Sangha, Randeep, McEwan, Alexander J.B., Morrish, Donald W., Arndt, Diane, Sergenson, Gwen, Cleton, Adriaan, Huang, Funan, Sawyer, Michael B.

Volltext

First-in-Human Phase I Trial of Two Schedules of OSI-930, a Novel Multikinase Inhibitor, Incorporating Translational Proof-of-Mechanism Studies von YAP, Timothy A, ARKENAU, Hendrik-Tobias, LEACH, Martin O, CHICK, Jon, POONDRU, Srinivasu, BOINPALLY, Ramesh, GEDRICH, Richard, BROCK, Katie, STEPHENS, Andrew, GAIL ECKHARDT, S, KAYE, Stan B, DEMETRI, George, ROSS CAMIDGE, D, SCURR, Michelle, GEORGE, Suzanne, SERKOVA, Natalie J, GWYTHER, Stephen J, SPRATLIN, Jennifer L, LAL, Rohit, SPICER, James, DESOUZA, Nandita M

Volltext

Looking to the future: biomarkers in the management of pancreatic adenocarcinoma von Spratlin, Jennifer L, Mulder, Karen E

Volltext

Human Equilibrative Nucleoside Transporter 1 (hENT1) in Pancreatic Adenocarcinoma: Towards Individualized Treatment Decisions von Spratlin, Jennifer L, Mackey, John R

Volltext

Accuracy of Resting Energy Expenditure Predictive Equations in Patients With Cancer von Purcell, Sarah A., Elliott, Sarah A., Baracos, Vickie E., Chu, Quincy S. C., Sawyer, Michael B., Mourtzakis, Marina, Easaw, Jacob C., Spratlin, Jennifer L., Siervo, Mario, Prado, Carla M.

Volltext

Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study von Skubleny, Daniel, Lin, Andrea, Garg, Saurabh, McLean, Ross, McCall, Michael, Ghosh, Sunita, Spratlin, Jennifer L, Schiller, Daniel, Rayat, Gina

Volltext

Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients von Sun, Julia, Ilich, Alastair I, Kim, Christina A, Chu, Michael P, Wong, Grace G, Ghosh, Sunita, Danilak, Melanie, Mulder, Karen E, Spratlin, Jennifer L, Chambers, Carole R, Sawyer, Michael B

Volltext

Predictive Impact of Clinical Benefit in Chemotherapy-treated Advanced Pancreatic Cancer Patients in Northern Alberta von Kim, Christina A, Chu, Quincy S C, Fassbender, Konrad, Ghosh, Sunita, Spratlin, Jennifer L

Volltext

Survival Impact of CAPOX Versus FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer von Loree, Jonathan M., Sha, Aaron, Soleimani, Maryam, Kennecke, Hagen F., Ho, Maria Y., Cheung, Winson Y., Mulder, Karen E., Abadi, Shirin, Spratlin, Jennifer L., Gill, Sharlene

Volltext

Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinoma von O'Sullivan, Dylan E, Boyne, Devon J, Syed, Iqra A, Shephard, Cal, Clouthier, Derek L, Yoshida, Eric M, Spratlin, Jennifer L, Batra, Atul, Rigo, Rodrigo, Hannouf, Malek, Yang Hu, Xun, N Jarada, Tamer, Brenner, Darren R, Cheung, Winson Y

Volltext

Effects of gender on capecitabine toxicity in colorectal cancer von Ilich, Alastair I, Danilak, Melanie, Kim, Christina A, Mulder, Karen E, Spratlin, Jennifer L, Ghosh, Sunita, Chambers, Carole R, Sawyer, Michael B

Volltext

CAPOX Associated With Toxicities of Higher Grade but Improved Disease-Free Survival When Compared With FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer von Loree, Jonathan M, Mulder, Karen E, Ghosh, Sunita, Spratlin, Jennifer L

Volltext

Efficacy and Safety of Single Agent or Combination Adjuvant Chemotherapy in Elderly Patients With Colon Cancer: A Canadian Cancer Institute Experience von Kim, Christina A.K, Spratlin, Jennifer L, Armstrong, Dawn E, Ghosh, Sunita, Mulder, Karen E

Volltext

Retrospective Comparison of CAPOX and FOLFOX Dose Intensity, Toxicity, and Clinical Outcomes in the Treatment of Metastatic Colon Cancer von Loree, Jonathan M., Mulder, Karen E., Ghosh, Sunita, Spratlin, Jennifer L.

Volltext

Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancer von Kim, Christina A. K., Price-Hiller, Julie, Chu, Quincy S., Tankel, Keith, Hennig, Ron, Sawyer, Michael B., Spratlin, Jennifer L.

Volltext

Impact of a Dedicated Cancer Center Surveillance Program on Guideline Adherence for Patients With Stage II and III Colorectal Cancer von Standeven, Leah, Price Hiller, Julie, Mulder, Karen, Zhu, George, Ghosh, Sunita, Spratlin, Jennifer L

Volltext

A 107-gene Nanostring assay effectively characterizes complex multiomic gastric cancer molecular classification in a translational patient-derived organoid model von Skubleny, Daniel, Purich, Kieran, Williams, Thomas, Wickware, Jim, Ghosh, Sunita, Spratlin, Jennifer L., Schiller, Dan E., Rayat, Gina

Volltext